Hypercvad Plus Imatinib or Dasatinib for Patients with Lymphoid Blastic Phase of Chronic Myeloid Leukemia

被引：0
|
作者：
Strati, Paolo [1 ]
Kantarjian, Hagop M. [1 ]
Thomas, Deborah A. [1 ]
O'Brien, Susan M. [1 ]
Jabbour, Elias J. [1 ]
Quintas-Cardama, Alfonso [1 ]
Borthakur, Gautam [1 ]
Faderl, Stefan [1 ]
Ravandi, Farhad [1 ]
Cortes, Jorge E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.3766.3766
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3766
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Combination of the Hypercvad Regimen with Dasatinib Is Effective in Patients with Relapsed Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL) and Lymphoid Blast Phase Chronic Myeloid Leukemia (CML-LB).
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Cortes, Jorge
    Thomas, Deborah A.
    Faderl, Stefan
    Jones, Dan
    Jabbour, Elias
    Koller, Charles
    Dara, Samuel
    Garris, Rebecca
    Kebriaei, Partow
    Borthakur, Gautam
    Ferrajoli, Alessandra
    O'Brien, Susan
    BLOOD, 2009, 114 (22) : 806 - 807
  • [32] Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation
    Milojkovic, Dragana
    Ibrahim, Amr
    Reid, Alistair
    Foroni, Letizia
    Apperley, Jane
    Marin, David
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03): : 473 - 474
  • [33] Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
    F J Giles
    E Abruzzese
    G Rosti
    D-W Kim
    R Bhatia
    A Bosly
    S Goldberg
    G L S Kam
    M Jagasia
    W Mendrek
    T Fischer
    T Facon
    U Dünzinger
    D Marin
    M C Mueller
    Y Shou
    N J Gallagher
    R A Larson
    F-X Mahon
    M Baccarani
    J Cortes
    H M Kantarjian
    Leukemia, 2010, 24 : 1299 - 1301
  • [34] Neuroendocrine tumor of cecum in patient treated with imatinib mesylate for blastic phase of chronic myeloid leukemia
    Novakovic, Sabina
    Peic, Anamarija Kovac
    Holik, Hrvoje
    Coha, Bozena
    ACTA CLINICA BELGICA, 2017, 72 (06) : 461 - 464
  • [35] Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
    Khoury, H. Jean
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Gambacorti-Passerini, Carlo
    Baccarani, Michele
    Kim, Dong-Wook
    Zaritskey, Andrey
    Countouriotis, Athena
    Besson, Nadine
    Leip, Eric
    Kelly, Virginia
    Bruemmendorf, Tim H.
    BLOOD, 2012, 119 (15) : 3403 - 3412
  • [36] Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
    Giles, F. J.
    Abruzzese, E.
    Rosti, G.
    Kim, D-W
    Bhatia, R.
    Bosly, A.
    Goldberg, S.
    Kam, G. L. S.
    Jagasia, M.
    Mendrek, W.
    Fischer, T.
    Facon, T.
    Duenzinger, U.
    Marin, D.
    Mueller, M. C.
    Shou, Y.
    Gallagher, N. J.
    Larson, R. A.
    Mahon, F-X
    Baccarani, M.
    Cortes, J.
    Kantarjian, H. M.
    LEUKEMIA, 2010, 24 (07) : 1299 - 1301
  • [37] ECONOMIC EVALUATION OF DASATINIB IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA IN PATIENTS RESISTANT TO IMATINIB IN CHILE
    Orozco, J. J.
    Valencia, J. E.
    Aiello, E.
    Caputo, M.
    VALUE IN HEALTH, 2011, 14 (07) : A543 - A543
  • [38] Economic evaluation of dasatinib in the treatment of chronic myeloid leukemia in patients resistant to imatinib in Chile
    Orozco Giraldo, John Jairo
    Valencia, Juan Esteban
    Aiello, Eleonora
    Caputo, Milva
    MEDWAVE, 2011, 11 (04):
  • [39] A Case with Neurofibromatosis and Chronic Myeloid Leukemia in Blastic Crisis Treated with Imatinib
    Hamid, Gamal Abdul
    Bin Harize, Iman
    MIDDLE EAST JOURNAL OF CANCER, 2014, 5 (02) : 105 - 108
  • [40] Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment
    Angriman, Federico
    Gutierrez Acevedo, Maria Nelly
    Sol Rossi, Maria
    Gimenez Conca, Alberto Daniel
    Otero, Victoria
    Alberto Arbelbide, Jorge
    Michelangelo, Hernan
    TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (02) : 193 - 194
12345